About this Journal Submit a Manuscript Table of Contents
Advances in Pharmacological Sciences
Volume 2012 (2012), Article ID 245431, 6 pages
http://dx.doi.org/10.1155/2012/245431
Research Article

Analgesic and Anti-Inflammatory Activity of Pinus roxburghii Sarg.

1Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra 136 119, India
2Rayat College of Pharmacy, Ropar, Punjab 144 533, India

Received 9 February 2012; Revised 25 April 2012; Accepted 25 April 2012

Academic Editor: Abdelwahab Omri

Copyright © 2012 Dhirender Kaushik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The Chir Pine, Pinus roxburghii, named after William Roxburgh, is a pine native to the Himalaya. Pinus roxburghii Sarg. (Pinaceae) is traditionally used for several medicinal purposes in India. As the oil of the plant is extensively used in number of herbal preparation for curing inflammatory disorders, the present study was undertaken to assess analgesic and anti-inflammatory activities of its bark extract. Dried and crushed leaves of Pinus roxburghii Sarg. were defatted with petroleum ether and then extracted with alcohol. The alcoholic extract at the doses of 100 mg/kg, 300 mg/kg, and 500 mg/kg body weight was subjected to evaluation of analgesic and anti-inflammatory activities in experimental animal models. Analgesic activity was evaluated by acetic acid-induced writhing and tail immersion tests in Swiss albino mice; acute and chronic anti-inflammatory activity was evaluated by carrageenan-induced paw oedema and cotton pellet granuloma in Wistar albino rats. Diclofenac sodium and indomethacin were employed as reference drugs for analgesic and anti-inflammatory studies, respectively. In the present study, the alcoholic bark extract of Pinus roxburghii Sarg. demonstrated significant analgesic and anti-inflammatory activities in the tested models.

1. Introduction

Inflammation is the response to injury of cells and body tissues through different factors such as infections, chemicals, and thermal and mechanical injuries [1]. Most of the anti-inflammatory drugs now available are potential inhibitors of cyclooxygenase (COX) pathway of arachidonic acid metabolism which produces prostaglandins. Prostaglandins are hyperalgesic, potent vasodilators and also contribute to erythema, edema, and pain. Hence, for treating inflammatory diseases, analgesic and anti-inflammatory agents are required [2]. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most clinically important medicine used for the treatment of inflammation-related diseases like arthritis, asthma, and cardiovascular disease [3]. Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely used medications due to their efficacy for a wide range of pain and inflammatory conditions [4]. However, the long-term administration of NSAID may induce gastro-intestinal ulcers, bleeding, and renal disorders due to their nonselective inhibition of both constitutive (COX-1) and inducible (COX-2) isoforms of the cyclooxygenases enzymes [57]. Therefore, new anti-inflammatory and analgesic drugs lacking those effects are being searched all over the world as alternatives to NSAIDs and opiates [8, 9]. Medicinal plants are believed to be an important source of new chemical substances with potential therapeutic effects. The research into plants with alleged folkloric use as pain relievers, anti-inflammatory agents, should therefore be viewed as a fruitful and logical research strategy in the search for new analgesic and anti-inflammatory drugs [10].

Pinus roxburghii Sarg. is the only tree with an ornamental specimen and having different medicinal values found in the Himalayan region of Bhutan, Nepal, Kashmir, Sikkim, Tibet and other parts of North India [11]. The plant is belonging to family Pinaceae commonly known as Chir Pine [12]. It consists of 110–120 species distributed throughout temperate regions of the Northern Hemisphere, and more than 40 taxonomic treatments have been recognized of several major divisions within the genus [13].

Pinus roxburghii Sarg. has many medicinal uses, the wood is aromatic, deodorant, haemostatic, stimulant, anthelmintic, digestive, liver tonic, diaphoretic, and diuretic. It is useful in eye, ear, and pharynx diseases, foul ulcers, haemorrhages, haemoptysis, worn infections, flatulence, liver diseases, bronchitis, inflammations, skin diseases, pruritus, and giddiness [11].

The chief chemical constituents of turpentine oil from Pinus roxburghii Sarg. are -pinene, -pinene, car-3-ene and longifolene [14, 15] hydrocarbons (d- and l-pinene), resin acids, camphene, fenchene, dipentene, and polymeric terpenes [16, 17].

Based on the above findings, Pinus roxburghii Sarg. bark extract was evaluated for its analgesic and anti-inflammatory effects on experimental induced pain and inflammation.

2. Material and Methods

2.1. Plant Material

The stems bark of Pinus roxburghii Sarg. were collected from the hilly region of Morni, District Panchkula, Haryana, in the month of December 2008 and was authenticated by FRI, Dehradun, Uttarakhand, India, where a voucher specimen no. 129 FHH was deposited for future reference.

2.2. Preparation of Extract

Shade dried coarse powdered bark of Pinus roxburghii Sarg. in a quantity sufficient as per the volume of extractor was packed in thimble (made of filter paper sheet). A sufficient volume of alcohol was added to the reservoir, and hot continuous extraction process in a Soxhlet extractor was started. This extraction process was continued for about 48 hours or until alcohol coming down the siphoning tube became colourless. The excess of alcohol was distilled under reduced pressure using rotatory vacuum evaporator. (Heidolph Laborota 4011, digital). A brown residue was recovered from flask with 12% yield.

2.3. HPLC Analysis

Samples of alcoholic bark extract of Pinus roxburghii Sarg. were analysed without any treatment.

The HPLC system (Shimadzu, Japan) consisted of a diode array detector (SPDM10AVP), solvent delivery module (LC-10ATVP), online degasser (DGU-14A), an autoinjector (SIL-10ADVP), flow channel system (FCV-14AH), system controller (SCL-10AVP), and a reversed-phase HPLC column (RP-18, 250 mm × 4.6 mm, 5 μm particle size, Sigma, USA). The flow rate of the HPLC was 1 ML/min, and the mobile phase 0.05% TFA in ACN: 0.05% TFA in water (gradient) for 70 min. Standards of chlorogenic acid, rutin and querctin were injected separately (10 ML). Chemical compounds in the samples were identified by comparison of their retention times (Rt) with the standards. Data analysis was carried out using Class VP V6.12 SP2 software (Shimadzu, Japan).

2.4. Animals

Wistar rats (150–250 gm) and Swiss albino mice (20–25 gm) of either sex, brought from National Institute of Pharmaceutical Education and Research, Mohali, were kept in the Animal House of Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra. Animals were housed at standard conditions of temperature (22 ± 1°C) and 12/12 h light/dark cycle. They were fed with standard pellet diet (Ashirwad Industries, Ropar, Punjab) and had free access to water. Five animals are used in each group. Permission for conduct of these experiments were obtained from, Institutional Animal Ethics Committee (IAEC).

2.5. Acute Toxicity Study

Toxicity studies conducted as per internationally accepted protocol drawn under OECD guidelines 425 in Swiss albino mice.

3. Pharmacological Activity

3.1. Anti-Inflammatory Activity
3.1.1. Carrageenan Induced Paw Edema Method

Carrageenan-induced paw inflammation was produced according to the method described by Winter et al. [18]. One hour after oral administration of the alcoholic extract of Pinus roxburghii Sarg. (100, 300, and 500 mg/kg), reference drug (indomethacin, 10 mg/kg) or vehicle (tween 80 (5%)), an injection of 0.1 ML of carrageenan (1% carrageenan suspended in 0.9% NaCl) was made into the right hind limb of each rat under the subplantar aponeurosis.

Measurement of paw volume was done by means of volume displacement technique using plethysmometer (Ugo Basile no. 7140) immediately after carrageenan injection and after 1, 2, 3, and 4 hr.

Percetages of inhibition were obtained using the following ratio: is the average volume for each group after treatment, and is the average volume for each group before any treatment.

3.1.2. Cotton Pellet Granuloma Method

Cotton pellet granulomas produced according to the method described by Winter and Porter [19]. Sterile cotton pellets (20 ± 0.5 mg) were implanted subcutaneously in the abdomen region of the rats. The animals received alcoholic bark extract of Pinus roxburghii Sarg. (100, 300 and 500 mg/kg), reference drug (diclofenac sodium, 50 mg/kg) or vehicle (tween 80 (5%)), orally, once a day through an oral cannula over seven consecutive days. On the 8th day, the rats were sacrificed, the cotton pellets removed, pellets dried up to constant weight at 60°C and the net dry weight, that is, after subtracting the weight of the cotton pellets, was determined.

3.2. Analgesic Activity
3.2.1. Acetic Acid Induced Writhing Test Method

The method used in this test has been described by Koster et al. [20]. The total number of writhings following intraperitoneal administration of acetic acid solution (1%, 10 mL/kg) was recorded over a period of 10 min, starting 5 min after acetic acid injection. The mice were treated with the alcoholic bark extract of Pinus roxburghii Sarg. (100, 300, and 500 mg/kg), or vehicle (tween 80 (5%)) or standard drug (diclofenac sodium, 50 mg/kg), 30 min before administration of acetic acid. The number of writhings and stretching was recorded and permitted to express the percentage of protection.

3.2.2. Tail Immersion Test in Rats

The procedure described by Aydin et al. [21] was used to conduct this test. 3 cm of the tail was introduced in hot water at a temperature of 55 ± 0.5°C. Within a few minutes, the rats reacted by withdrawing the tail. The reaction time was recorded with a stopwatch. The animals were treated by alcoholic extract of Pinus roxburghii Sarg. (100, 300 and 500 mg/kg), or water (vehicle) or standard drug (diclofenac sodium, 50 mg/kg), 30 min before the immersion of the tail. The time reaction is taken at 1, 2, 3, and 4 after administration of different preparations.

3.2.3. Statstical Analysis

All values were expressed as mean ± SEM, and data was analyzed by one way analysis of variance (ANOVA) followed by Dunnett's  -test using GraphPad InStat.

4. Results

4.1. Acute Toxicity Test of Plant Extract

Alcoholic extract of the plant Pinus roxburghii Sarg. was found safe at the dose of 5000 mg/kg according to OECD guidelines 425.

4.2. HPLC Analysis

A correct assignment to the various compounds was not possible. From UV spectra and retention times of the main peaks, some compound classes contained in the extract have been determined. High-performance liquid chromatography (HPLC) revealed the presence of bioflavonoids, quercetin, chlorogenic acid, and rutin (Figure 1).

245431.fig.001
Figure 1: HPLC analysis of  Pinus roxburghii Sarg. (Pinaceae) showing presence of chlorogenic acid (1), rutin (2) and quercetin (3).
4.3. Anti-Inflammatory Activity
4.3.1. Carrageenan-Induced Paw Edema in Rats

In the carrageenan-induced oedema test, the paw volumes and percentages of ages of inhibition by the alcoholic extract of Pinus roxburghii Sarg. and standard drugs are shown in Table 1. Injection of carrageenan was done 1 h after oral administration of the extract (100, 300, and 500 mg/kg), indomethacin (reference drug) and water. Measurement of paw size was taken before carrageenan injection and then 1, 2, 3, and 4 h after carrageenan injection. The alcoholic extract of Pinus roxburghii Sarg. at all doses showed a significant inhibition of paw oedema at third hour as compared to reference drug (Table 1).

tab1
Table 1: Protective efeect of Pinus roxburghii Sarg. on paw edema induced by carrageenan in rat.
4.3.2. Cotton Pellet Granuloma

Table 2 shows that the alcoholic bark extract of Pinus roxburghii Sarg. exhibited a significant and dose-related inhibition of the dried weight of the cotton pellet granuloma. The inhibitory values for 100, 300, and 500 mg/kg of the extract were 31.11%, 36.13% and 56.93% (), respectively. Diclofenac sodium (reference drug) and water inhibited granuloma tissue formation with a value of 92.87 () %, a slightly higher value than that observed with the 80 mg/kg dose of the Pinus roxburghii Sarg. extract.

tab2
Table 2: Protective efeect of Pinus roxburghii Sarg. on cotton pellet induced granuloma.
4.4. Analgesic Activity
4.4.1. Acetic Acid Induced Writhing Test in Mice

The alcoholic extract of Pinus roxburghii Sarg. (100, 300, and 500 mg/kg) dose significantly and dependently reduced the number of abdominal constriction induced in mice by a solution of acetic acid 1%. This dose-dependent protective effect reached a maximum inhibition of 80.95% at the dose of 500 mg/kg. Diclofenac sodium (reference drug) exerted a significant protective effect, with percentage of protection of 90 (Table 3).

tab3
Table 3: Protective efeect of Pinus roxburghii Sarg. on writhing induced by acetic acid.
4.4.2. Tail Immersion Test in Rats

As presented in Table 4, alcoholic extract of Pinus roxburghii Sarg. in doses of 500 mg/kg () body weight showed a significant elongation of reaction time, 30 minutes after oral administration of the extract. After 60 minutes, the alcoholic extract of Pinus roxburghii Sarg. in doses of 300 mg/kg () and 500 mg/kg () body weight showed a significant elongation. After 90 minutes alcoholic extract of Pinus roxburghii Sarg. in doses of 300 mg/kg () and 500 mg/kg body weight showed a significant () elongation of reaction time. After 120 minutes alcoholic extract of Pinus roxburghii Sarg. in doses of 100 mg, 300 mg, and 500 mg/kg body weight showed no significant elongation of reaction time.

tab4
Table 4: Protective efeect of Pinus roxburghii Sarg. on tail withdrawal reflex induced by tail immersion.

5. Discussions

Carrageenan-induced edema has been commonly used as an experimental animal model for acute inflammation and is believed to be biphasic. The early phase (1-2 h) of the carrageenan model is mainly mediated by histamine, serotonin, and increased synthesis of prostaglandins in the damaged tissue surroundings. The late phase is sustained by prostaglandin release and mediated by bradykinin, leukotrienes, polymorphonuclear cells, and prostaglandins produced by tissue macrophages [10, 22]. Since the extract/fractions significantly inhibited paw edema induced by carrageenan in the second phase, this finding suggests a possible inhibition of cyclooxygenase synthesis by the extract and this effect is similar to that produced by nonsteroidal anti-inflammatory drugs such as indomethacin, whose mechanism of action is inhibition of the cyclooxygenase enzyme.

The inflammatory granuloma is a typical feature of an established chronic inflammatory process [23, 24]. The cotton pellet granuloma method has been widely employed to evaluate the transudative, exudative, and proliferative components of chronic inflammation, because the dried weight of the pellets correlates well with the amount of granulomatous tissue [25]. We found a dose-dependent inhibition of granuloma formation in mice, suggesting that the aqueous stem bark extract of Pinus roxburghii Sarg. inhibits chronic inflammation processes during the late phases of acute inflammation.

The brain and spinal cord play a major role in central pain mechanisms. The dorsal horn of the spinal cord is endowed with several neurotransmitters and receptors including substance P, somatostatin, neuropeptide Y, inhibitory amino acid, nitric oxide, endogenous opioids, and the monoamines which are the major targets for pain and inflammation [26]. The tail immersion test was considered to be selective to examine compounds acting through opioid receptor; all the extract/fractions increased pain threshold which means basal latency, which indicates that it may act via centrally mediated analgesic mechanism. Narcotic analgesics inhibit both peripheral and central mechanism of pain, while nonsteroidal anti-inflammatory drugs inhibit only peripheral pain [27]. The extract inhibits pain with both mechanisms, suggesting that the plant extract may act as a narcotic analgesic. On the other hand, acetic acid-induced writhing model represents pain sensation by triggering localized inflammatory response. Such pain stimulus leads to the release of free arachidonic acid from the tissue phospholipid [28]. The acetic acid induced writhing response is a sensitive procedure to evaluate peripherally acting analgesics. The response is thought to be mediated by peritoneal mast cells [29], acid sensing ion channels [30], and the prostaglandin pathways [31]. Flavonoids may increase the amount of endogenous serotonin or may interact with 5-HT2A and 5-HT3 receptors which may be involved in the mechanism of central analgesic activity [32]. Moreover, EtOAc extract showed highest analgesic activity in all the experimental modelo which may be due to its high flavonsid contents which are responsible for free radical scavenging activity, as these free radicals are involved during pain stimulation, and antioxidants showed reduction in such pain [33].

The results of the present study have shown that the crude extract of the investigated plant exhibited very high anti-inflammatory and analgesic activities. These activities may be linked with the presence of polyphenolic compounds present in the extract. The HPLC analysis of AB extract shows the presence of bioflavonoids, quercetin, and rutin, which are reported to be anti-inflammatory, antiasthmatic, analgesic anti-inflammatory, and antioxidant, and these findings are in concordance with our results. Many plants containing flavonoids have been shown to have diuretic, laxative, antispasmodic, anti-hypertensive, and anti-inflammatory actions [34]. Flavonoids and saponins are well known for their ability to inhibit pain perception as well as anti-inflammatory properties due to their inhibitory effects on enzymes involved in the production of the chemical mediator of inflammation [35].

The ability of flavonoids to inhibit eicosanoid biosynthesis has been documented. Eicosanoids, such as prostaglandins, are involved in various immunological responses and are the end products of the cyclooxygenase and lipoxygenase pathways [36]. Further, flavonoids are able to inhibit neutrophils degranulation and thereby decrease the release of arachidonic acid [37]. Thus, the presence of flavonoids in the extract/fractions of Pinus roxburghii Sarg. might be responsible for the anti-inflammatory and analgesic activity in Swiss albino mice and rats.

References

  1. O. A. Oyedapo, C. O. Adewunmi, E. O. Iwalewa, and V. O. Makanju, “Analgesic, antioxidant and anti-inflammatory related activities of 21-hydroxy-2,41-dimethoxychalcone and 4-hydroxychalcone in mice,” Journal of Biological Sciences, vol. 8, no. 1, pp. 131–136, 2008. View at Scopus
  2. M. Anilkumar, “Ethnomedicinal plants as anti-inflammatory and analgesic agents,” in Ethnomedicine: A Source of Complementary Therapeutics, pp. 267–293, Research Signpost, India, 2010.
  3. F. Conforti, S. Sosa, M. Marrelli et al., “The protective ability of Mediterranean dietary plants against the oxidative damage: the role of radical oxygen species in inflammation and the polyphenol, flavonoid and sterol contents,” Food Chemistry, vol. 112, no. 3, pp. 587–594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. IMS Health, IMS National Sales Perspectives TM, 2005.
  5. A. Robert, “Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins,” Advances in Prostaglandin and Thromboxane Research, vol. 2, pp. 507–520, 1976. View at Scopus
  6. B. M. Peskar, “On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs,” Biochimica et Biophysica Acta, vol. 487, no. 2, pp. 307–314, 1977. View at Scopus
  7. H. Tapiero, G. Nguyen Ba, P. Couvreur, and K. D. Tew, “Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies,” Biomedicine and Pharmacotherapy, vol. 56, no. 5, pp. 215–222, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. G. Dharmasiri, J. R. A. C. Jayakody, G. Galhena, S. S. P. Liyanage, and W. D. Ratnasooriya, “Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo,” Journal of Ethnopharmacology, vol. 87, no. 2-3, pp. 199–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Kumara, “Identification of strategies to improve research on medicinal plants used in Sri Lanka,” in Proceedings of the WHO Symposium, pp. 12–14, University of Ruhuna, Galle, Sri Lanka, 2001.
  10. M. Gupta, U. K. Mazumder, P. Gomathi, and V. T. Selvan, “Antiinflammatory evaluation of leaves of Plumeria acuminata,” BMC Complementary and Alternative Medicine, vol. 6, article 36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. J. Earle, “Pinus roxburghii Sargent 1897,” http://www.conifers.org/pi/pin/roxburghii.htm.
  12. B. Sharad and A. Bohra, “Antibacterial potential of three naked-seeded (Gymnosperm) plants,” Natural Product Radiance, vol. 7, no. 5, pp. 420–425, 2008. View at Scopus
  13. A. J. Eckert and B. D. Hall, “Phylogeny, historical biogeography, and patterns of diversification for Pinus (Pinaceae): phylogenetic tests of fossil-based hypotheses,” Molecular Phylogenetics and Evolution, vol. 40, no. 1, pp. 166–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. V. P. S. Verma and R. K. Suri, “Geographic variation in the chemical composition of turpentine oil of chirpine (PrS),” Indian Perfumer, vol. 22, pp. 179–181, 1978.
  15. M. Smaleh, O. P. Sharma, and N. P. Dobhal, “Chemical composition of turpentine oil from pleoresin (Pinus roxburghii Sargent) Indian oerfumer,” Chemistry of Forest Products Branch, vol. 20, pp. 15–19, 1976.
  16. S. Rastogi, A. Shukla, and S. A. Kolhapure, “Evaluation of the clinical efficacy and safety of RG-01 (Rumalaya gel) in the management of chronic sub-acute inflammatory joint disorder,” Medicine Update, vol. 12, no. 1, pp. 31–37, 2004.
  17. A. Sharma and S. A. Kolhapure, “Evaluation of the efficacy and safety of Rumalaya gel in the management of acute and chronic inflammatory musculoskeltal disorders: an open, prospective, noncomparative, phase III clinical trial,” Medicine Update, vol. 12, no. 10, pp. 39–45, 2005.
  18. C. A. Winter, E. A. Risley, and G. W. Nuss, “Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs,” Proceedings of the Society for Experimental Biology and Medicine, vol. 111, pp. 544–547, 1962. View at Scopus
  19. C. A. Winter and C. C. Porter, “Effect of alterations in the side chain upon antiinflammatory and liver glycogen activities of hydrocortisone esters,” Journal of the American Pharmaceutical Association, vol. 46, pp. 515–519, 1957.
  20. R. Koster, M. Anderson, and J. De Beer, “Acetic acid for analgesic screening,” Federation Proceedings, vol. 18, pp. 412–417, 1959.
  21. S. Aydin, T. Demir, Y. Ozturk, et al., “Analgesic activity of Nepeta italica L,” Phytotherapy Research, vol. 13, pp. 20–23, 1999.
  22. M. A. Antônio and A. R. M. Souza Brito, “Oral anti-inflammatory and anti-ulcerogenic activities of a hydroalcoholic extract and partitioned fractions of Turnera ulmifolia (Turneraceae),” Journal of Ethnopharmacology, vol. 61, no. 3, pp. 215–228, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Vane and R. M. Botting, “New insights into the mode of action of anti-inflammatory drugs,” Inflammation Research, vol. 44, no. 1, pp. 1–10, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. Perianayagam, S. K. Sharma, and K. K. Pillai, “Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals,” Journal of Ethnopharmacology, vol. 104, no. 3, pp. 410–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. F. Swingle and F. E. Shideman, “Phases of the inflammatory response to subcutaneous implantation of a cotton pellet and their modification by certain anti-inflammatory agents,” Journal of Pharmacology and Experimental Therapeutics, vol. 183, no. 1, pp. 226–234, 1972. View at Scopus
  26. C. R. McCurdy and S. S. Scully, “Analgesic substances derived from natural products (natureceuticals),” Life Sciences, vol. 78, no. 5, pp. 476–484, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Elisabetsky, T. A. Arnador, R. R. Albuquerque, D. S. Nunes, and A. Do CT Carvalho, “Analgesic activity of Psychotria colorata (Willd. ex R. and S.) Muell. Arg. alkaloids,” Journal of Ethnopharmacology, vol. 48, no. 2, pp. 77–83, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Ahmed, M. H. Hossain, A. A. Rahman, et al., “Antinociceptive and sedative effects of the bark of Cerbera odollam Gaertn,” International Journal of Oriental Pharmacy and Experimental Medicine, vol. 6, pp. 344–348, 2006.
  29. R. A. Ribeiro, M. L. Vale, S. M. Thomazzi et al., “Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice,” European Journal of Pharmacology, vol. 387, no. 1, pp. 111–118, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Voilley, “Acid-sensing ion channels (ASICs): new targets for the analgesic effects of non-steroid anti-inflammatory drugs (NSAIDs),” Current Drug Targets, vol. 3, no. 1, pp. 71–79, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. M. Hossain, M. S. Ali, A. Saha, et al., “Antinociceptive activity of whole plant extracts of Paederia foetida,” Dhaka University Journal of Pharmaceutical Sciences, vol. 5, pp. 67–69, 2006.
  32. H. V. Annegowda, M. N. Mordi, S. Ramanathan, and S. M. Mansor, “Analgesic and antioxidant properties of ethanolic extract of Terminalia catappa L. leaves,” International Journal of Pharmacology, vol. 6, no. 6, pp. 910–915, 2010. View at Scopus
  33. H. K. Kim, S. K. Park, J. L. Zhou et al., “Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain,” Pain, vol. 111, no. 1-2, pp. 116–124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Okuda, “Flavonoids,” in Chemistry of Organic Natural Products, H. Mitsuhashi, O. Tanaka, S. Nazoe, and M. Nagai Nankodo, Eds., pp. 219–228, Tokyo, Japan, 1962.
  35. W. R. Sawadogo, R. Boly, M. Lompo et al., “Anti-inflammatory, analgesic and antipyretic activities of Dicliptera verticillata,” International Journal of Pharmacology, vol. 2, no. 4, pp. 435–438, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Jothimanivannan, R. S. Kumar, and N. Subramanian, “Anti-inflammatory and analgesic activities of ethanol extract of aerial parts of Justicia gendarussa Burm,” International Journal of Pharmacology, vol. 6, pp. 278–283, 2010.
  37. J. R. S. Hoult, M. A. Moroney, and M. Paya, “Actions of flavonoids and coumarins on lipoxygenase and cyclooxygenase,” Methods in Enzymology, vol. 234, pp. 443–454, 1994. View at Publisher · View at Google Scholar · View at Scopus